196 related articles for article (PubMed ID: 34988689)
1. T follicular helper cells improve the response of patients with chronic hepatitis B to interferon by promoting HBsAb production.
Liu Y; Hu X; Hu X; Yu L; Ji H; Li W; Cai Y; Cheng G; Jiang Y
J Gastroenterol; 2022 Jan; 57(1):30-45. PubMed ID: 34988689
[TBL] [Abstract][Full Text] [Related]
2. Follicular Helper T (T
Ayithan N; Tang L; Tan SK; Chen D; Wallin JJ; Fletcher SP; Kottilil S; Poonia B
Front Immunol; 2021; 12():735913. PubMed ID: 34512670
[TBL] [Abstract][Full Text] [Related]
3. Bushen Formula promotes the decrease of HBsAg levels in patients with CHB by regulating Tfh cells and B-cell subsets.
Ji L; Wei J; Zhang R; Zhang X; Gao Y; Fang M; Yu Z; Cao L; Gao Y; Li M
J Ethnopharmacol; 2024 Jun; 328():118072. PubMed ID: 38508431
[TBL] [Abstract][Full Text] [Related]
4. Circulating Th2-biased T follicular helper cells impede antiviral humoral responses during chronic hepatitis B infection through upregulating CTLA4.
Yin S; Wang J; Chen L; Mao M; Issa R; Geng Y; Huang R; Tong X; Liu Y; Wu C; Chen Y; Li J
Antiviral Res; 2023 Aug; 216():105665. PubMed ID: 37421985
[TBL] [Abstract][Full Text] [Related]
5. Circulating PD-1
Zhang L; Li H; Ren H; Hu P
Mol Immunol; 2018 Nov; 103():270-278. PubMed ID: 30340072
[TBL] [Abstract][Full Text] [Related]
6. High frequency of CD4+ CXCR5+ TFH cells in patients with immune-active chronic hepatitis B.
Feng J; Lu L; Hua C; Qin L; Zhao P; Wang J; Wang Y; Li W; Shi X; Jiang Y
PLoS One; 2011; 6(7):e21698. PubMed ID: 21750724
[TBL] [Abstract][Full Text] [Related]
7. Follicular helper T cell and memory B cell immunity in CHC patients.
Liu Y; Ji H; Zhao P; Yan H; Cai Y; Yu L; Hu X; Sun X; Jiang Y
J Mol Med (Berl); 2019 Mar; 97(3):397-407. PubMed ID: 30666346
[TBL] [Abstract][Full Text] [Related]
8. End-of-treatment HBcrAg and HBsAb levels identify durable functional cure after Peg-IFN-based therapy in patients with CHB.
Huang D; Wu D; Wang P; Wang Y; Yuan W; Hu D; Hu J; Wang Y; Tao R; Xiao F; Zhang X; Wang X; Han M; Luo X; Yan W; Ning Q
J Hepatol; 2022 Jul; 77(1):42-54. PubMed ID: 35149125
[TBL] [Abstract][Full Text] [Related]
9. Tfh cell-mediated humoral immune response and HBsAg level can predict HBeAg seroconversion in chronic hepatitis B patients receiving peginterferon-α therapy.
Zhang L; Zhang M; Li H; Chen Z; Luo A; Liu B; Chen M; Peng M; Ren H; Hu P
Mol Immunol; 2016 May; 73():37-45. PubMed ID: 27037894
[TBL] [Abstract][Full Text] [Related]
10. Immune correlates of hepatitis B surface antigen spontaneous seroconversion in hepatitis B e antigen negative chronic hepatitis B patients.
Vyas AK; Sharma BC; Sarin SK; Trehanpati N
Liver Int; 2018 Jan; 38(1):38-49. PubMed ID: 28500636
[TBL] [Abstract][Full Text] [Related]
11. Expansion of circulating TFH cells and their associated molecules: involvement in the immune landscape in patients with chronic HBV infection.
Hu TT; Song XF; Lei Y; Hu HD; Ren H; Hu P
Virol J; 2014 Mar; 11():54. PubMed ID: 24655429
[TBL] [Abstract][Full Text] [Related]
12. Add-on pegylated interferon augments hepatitis B surface antigen clearance
Wu FP; Yang Y; Li M; Liu YX; Li YP; Wang WJ; Shi JJ; Zhang X; Jia XL; Dang SS
World J Gastroenterol; 2020 Apr; 26(13):1525-1539. PubMed ID: 32308352
[TBL] [Abstract][Full Text] [Related]
13. Toll-like receptor 7 agonist, GS-986, is an immune-stimulant inducing follicular helper T cells and expanding HBs antigen-specific B cells in vitro.
Mori T; Yoshio S; Yoshikawa S; Tsustui Y; Sakata T; Yoshida Y; Sakamoto Y; Kawai H; Osawa Y; Yamazoe T; Aoki Y; Fletcher SP; Kanto T
Liver Int; 2023 Jun; 43(6):1213-1224. PubMed ID: 37029645
[TBL] [Abstract][Full Text] [Related]
14. Dysregulated Response of Follicular Helper T Cells to Hepatitis B Surface Antigen Promotes HBV Persistence in Mice and Associates With Outcomes of Patients.
Wang X; Dong Q; Li Q; Li Y; Zhao D; Sun J; Fu J; Meng F; Lin H; Luan J; Liu B; Wang M; Wang FS; He F; Tang L
Gastroenterology; 2018 Jun; 154(8):2222-2236. PubMed ID: 29544722
[TBL] [Abstract][Full Text] [Related]
15. Circulating T follicular helper cells are associated with rapid virological response in chronic hepatitis C patients undergoing peginterferon therapy.
Zhang M; Zhang L; Li H; Chen Z; Luo A; Liu B; Chen M; Peng M; Ren H; Hu P
Int Immunopharmacol; 2016 May; 34():235-243. PubMed ID: 26971227
[TBL] [Abstract][Full Text] [Related]
16. Clinical Analysis of Polyethylene Glycol Interferon-α Treatment in 155 Hepatitis B e Antigen (HBeAg)-Positive Chronic Hepatitis B (CHB) Patients.
Luo X; Yu JX; Xie L; Ma WJ; Wang LH
Ann Hepatol; 2017 November-December,; 16(6):888-892. PubMed ID: 29055925
[TBL] [Abstract][Full Text] [Related]
17. Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.
Shepherd J; Jones J; Takeda A; Davidson P; Price A
Health Technol Assess; 2006 Aug; 10(28):iii-iv, xi-xiv, 1-183. PubMed ID: 16904047
[TBL] [Abstract][Full Text] [Related]
18. Upregulation of NKG2C+ natural killer cells, TLR-2 expression on monocytes and downregulation of regulatory T-cells influence PEG-IFN treatment efficacy in entecavir-suppressed patients with CHB.
Yan W; Wu D; Wang X; Chen T; Lai Q; Zheng Q; Jiang J; Hou J; Han M; Ning Q
Antivir Ther; 2015; 20(6):591-602. PubMed ID: 25814467
[TBL] [Abstract][Full Text] [Related]
19. Recovery of circulating CD56
Liu N; Liu B; Zhang L; Li H; Chen Z; Luo A; Chen M; Peng M; Yin W; Ren H; Hu P
Int Immunopharmacol; 2018 Sep; 62():59-66. PubMed ID: 29990695
[TBL] [Abstract][Full Text] [Related]
20. Effect of Pegylated Interferon Plus Tenofovir Combination on Higher Hepatitis B Surface Antigen Loss in Treatment-naive Patients With Hepatitis B e Antigen -positive Chronic Hepatitis B: A Real-world Experience.
Hu C; Song Y; Tang C; Li M; Liu J; Liu J; Liao M; Zhou F; Zhang YY; Zhou Y
Clin Ther; 2021 Mar; 43(3):572-581.e3. PubMed ID: 33516527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
